Medical Devices China

China Nebulizers Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

China Nebulizers Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $106.2 Mn Placeholder estimate
Estimate 2025 $114.5 Mn 7.8% of the global market
Projected 2034 $225.0 Mn 96.6% Adds $110.6 Mn over 9 forecast years
CAGR 2025–2034 7.8% Faster than 20% of 173 Medical Devices markets here
Key players 5
  • China is 7.84% of the global market.
  • In APAC, the largest is China (this report) at $114.5 Mn.
  • Fastest growing: India at 9.3% a year.
  • China ranks 1st of 10 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$110.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Nebulizers Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $106.2 Mn — —
2025 (base) $114.5 Mn +$8.3 Mn —
2026 (forecast) $123.4 Mn +$8.9 Mn +7.8%
2027 (forecast) $133.0 Mn +$9.6 Mn +16.2%
2028 (forecast) $143.4 Mn +$10.4 Mn +25.3%
2029 (forecast) $154.6 Mn +$11.2 Mn +35%
2030 (forecast) $166.6 Mn +$12.1 Mn +45.6%
2031 (forecast) $179.6 Mn +$13.0 Mn +56.9%
2032 (forecast) $193.6 Mn +$14.0 Mn +69.2%
2033 (forecast) $208.7 Mn +$15.1 Mn +82.4%
2034 (forecast) $225.0 Mn +$16.3 Mn +96.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.46 Bn
  2. North America $673.2 Mn
  3. US $595.4 Mn
  4. APAC $327.6 Mn
  5. Europe $262.6 Mn
  6. Canada $128.6 Mn
  7. China (this report) $114.5 Mn
  8. Japan $104.9 Mn
  9. Middle East $63.6 Mn
  10. Latin America $61.8 Mn
  11. Germany $54.0 Mn
  12. France $42.0 Mn
  13. Brazil $41.1 Mn
  14. Italy $35.3 Mn
  15. UK $34.2 Mn
  16. Spain $31.8 Mn
  17. Ecuador $32.5 Mn
  18. India $32.4 Mn
  19. Saudi Arabia $28.1 Mn
  20. Africa $23.4 Mn
  21. Mexico $20.8 Mn
  22. Australia $18.8 Mn
  23. Russia $15.8 Mn
  24. New Zealand $15.1 Mn
  25. South Africa $8.5 Mn
  26. UAE $7.5 Mn
  27. Egypt $3.6 Mn
  28. Philippines $2.8 Mn
  29. Hong Kong $2.6 Mn
  30. Malaysia $2.6 Mn
  31. Thailand $1.9 Mn
  32. Singapore $1.8 Mn
  33. Kenya $0.9 Mn

Report snapshot

China Nebulizers Market Analysis at a glance
Market size, 2025$114.5 Mn placeholder estimate
Forecast, 2034$225.0 Mn placeholder estimate
Growth (CAGR), 2025–20347.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and end user (see all)
Key playersPhilips Healthcare, Omron Healthcare, PARI, Aerogen, Drive DeVilbiss Healthcare (see all)
Regulator in ChinaNMPASource: National Medical Products Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The China Nebulizers Market Analysis Executive Summary

Nebulizers turn liquid medicine into a mist that is breathed into the lungs, used for asthma, COPD and cystic fibrosis.

Key segments of the nebulizers market include product (Jet Nebulizers, Mesh Nebulizers and Ultrasonic Nebulizers) and setting (Home, Hospitals and Clinics).

Bar chart: China Nebulizers market size, 2024–2034, placeholder estimates. $106.2 Mn in 2024, $114.5 Mn in 2025 and $225.0 Mn in 2034, 7.8% CAGR.
China Nebulizers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

China Nebulizers Market Dynamics

Market Growth Drivers

Rising rates of sleep apnea, sinus disease and hearing loss, an ageing population and less invasive treatments are driving the nebulizers market.

Opportunity

Home-based diagnosis, smaller connected devices and office-based procedures give the nebulizers market room to grow.

Market Restraints

Device costs, patients stopping therapy, limited reimbursement and supply issues after recalls hold back the nebulizers market.

Competitive Landscape for Nebulizers Market in China

The nebulizers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Nebulizers Market in China

Nebulizers in China: rules and payment

Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered.⁠[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.⁠[2]

[1] National Medical Products Administration. Checked 14 Nov 2026.

[2] National Healthcare Security Administration. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how nebulizers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in China.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Nebulizers right now, from free public sources.

Latest research 350 papers since 2021 (worldwide)

  1. A Qualitative Study Exploring the Perspectives of Individuals with COPD and Caregivers on COPD Maintenance Treatments in the United States. Patient preference and adherence, 2026
  2. Assessment of Preparedness for Medical Emergencies in Saudi Dental Colleges: A National Cross-Sectional Study. European journal of dental education : official journal of the Association for Dental Education in Europe, 2026
  3. Assessment of teachers' knowledge, awareness, and response to students with asthma in Greater Cairo schools. NPJ primary care respiratory medicine, 2026
  4. Design and evaluation of a breath-synchronized smart vibrating mesh nebulizer: from instrumentation to human pharmacokinetics. International journal of pharmaceutics, 2026
  5. Effect of Nebulizer Breath-Guiding on Breathing Patterns and Lung Deposition. Journal of aerosol medicine and pulmonary drug delivery, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Nebulizers in context

China compared

  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 6th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Nebulizers market in China?
Placeholder estimate: about $114.5 Mn in 2025, rising to about $225.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Nebulizers market in China growing?
Placeholder estimate: about 7.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Nebulizers market report cover?
The report splits the market by product (Jet Nebulizers, Mesh Nebulizers, Ultrasonic Nebulizers), setting (Home, Hospitals, Clinics) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Nebulizers market?
Key players include Philips Healthcare, Omron Healthcare, PARI, Aerogen and Drive DeVilbiss Healthcare.
What is driving the Nebulizers market?
Rising rates of sleep apnea, sinus disease and hearing loss, an ageing population and less invasive treatments are driving the nebulizers market.
Who regulates Nebulizers in China?
Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered. Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How much research is published on Nebulizers?
PubMed lists 350 papers on Nebulizers added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Nebulizers in China? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Airway Management Devices: Critical Tools in EmergenciesKeeping the airway open is the first step in saving a life. More than half of deaths in low- and… Anaesthesia and Respiratory Devices: Lessons After COVIDMore than 5 billion people lack access to safe, affordable medical oxygen. COVID-19 exposed gaps in… Snoring and Sleep Apnoea Devices: Sleeping BetterAn estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
Back to Catalogue
Keep exploring

Related Medical Devices reports in China

See all
Same topic, other categories

Related on respiratory and home and long-term care

See the topic